Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Namzaric

×

Overview

What is Namzaric?

NAMZARIC contains memantine, an orally active NMDA receptor antagonist, as the hydrochloride salt and donepezil, a reversible inhibitor of the enzyme acetylcholinesterase, as the hydrochloride salt.



What does Namzaric look like?



What are the available doses of Namzaric?

-Extended-Release Capsules:

What should I talk to my health care provider before I take Namzaric?

How should I use Namzaric?


What interacts with Namzaric?

Sorry No Records found


What are the warnings of Namzaric?

Sorry No Records found


What are the precautions of Namzaric?

Sorry No Records found


What are the side effects of Namzaric?

Sorry No records found


What should I look out for while using Namzaric?

NAMZARIC is contraindicated in patients with known hypersensitivity to memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation.


What might happen if I take too much Namzaric?

Memantine hydrochloride and donepezil hydrochloride are the two active ingredients of NAMZARIC. No specific antidote for memantine hydrochloride overdose is known; however, elimination of memantine can be increased by acidification of the urine. Tertiary anticholinergics such as atropine may be used as an antidote for donepezil hydrochloride overdose. In managing cases of overdose, consider the possibility of multiple drug involvement. In case of overdose, call Poison Control Center at 1-800-222-1222 for the latest recommendation. In general, supportive measures should be utilized, and treatment should be symptomatic.


How should I store and handle Namzaric?

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) . Dispense in a tight, light-resistant container, as defined in the USP. Product: 63629-3325NDC: 63629-3325-2 60 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-1 90 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-3 30 CAPSULE, EXTENDED RELEASE in a BOTTLEProduct: 63629-3325NDC: 63629-3325-2 60 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-1 90 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-3 30 CAPSULE, EXTENDED RELEASE in a BOTTLEProduct: 63629-3325NDC: 63629-3325-2 60 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-1 90 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-3 30 CAPSULE, EXTENDED RELEASE in a BOTTLEProduct: 63629-3325NDC: 63629-3325-2 60 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-1 90 CAPSULE, EXTENDED RELEASE in a BOTTLENDC: 63629-3325-3 30 CAPSULE, EXTENDED RELEASE in a BOTTLE


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

NAMZARIC capsules contain two approved medications: memantine hydrochloride and donepezil hydrochloride. Each of those medications is postulated to have a different mechanism in Alzheimer's disease.

Non-Clinical Toxicology
NAMZARIC is contraindicated in patients with known hypersensitivity to memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation.

As with all drugs, the potential for interaction by a variety of mechanisms is a possibility.

Donepezil hydrochloride, an active ingredient in NAMZARIC, as a cholinesterase inhibitor, is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia.

The following serious adverse reactions are discussed below and elsewhere in the labeling.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).